Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients

OBJECTIVE: The efficacy of tocilizumab (TCZ) in GCA is supported by two randomized controlled studies, in which TCZ allowed remission to be achieved after 52 weeks of treatment. However, after discontinuation of treatment, half of the patients relapsed. The aim of this study was to analyse the effic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Rheumatol Adv Pract
Egile Nagusiak: Regola, Francesca, Cerudelli, Elisabetta, Bosio, Giovanni, Andreoli, Laura, Tincani, Angela, Franceschini, Franco, Toniati, Paola
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7359771/
https://ncbi.nlm.nih.gov/pubmed/32685912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa017
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak